17 episodes

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
See acast.com/privacy for privacy and opt-out information.

eMultipleSclerosis Review eMultipleSclerosis Review

    • Health & Fitness
    • 5.0 • 1 Rating

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
See acast.com/privacy for privacy and opt-out information.

    Is that MS Diagnosis Accurate?

    Is that MS Diagnosis Accurate?

    Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags — warnings that something about the patient’s condition does not meet the accepted MS diagnostic criteria — that need to be investigated?   
    Join us in this eMultipleSclerosis Review podcast, as Neuroimmunologist Dr. Gabrielle Macaron from Saint Joseph University’s Hotel Dieu de France Hospital in Beirut, Lebanon, and the Cleveland Clinic’s Mellen Center for Multiple Sclerosis, explains strategies to reduce misdiagnosis of MS. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 25 min
    Nonpharmacologic Symptom Management

    Nonpharmacologic Symptom Management

    In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What doesn’t? What does the evidence say? 
    Join us as Dr. W. Oliver Tobin from the Mayo Clinic discusses these questions in this eMultipleSclerosis Review podcast.
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 25 min
    Treatment Considerations for Aging Patients

    Treatment Considerations for Aging Patients

    As people with MS age, how does their response to their long-term DMT change? Is there a time when disease-modifying therapy can be safely discontinued? In which patients? At what age? What role do comorbidities play in making these decisions?  
    Join us as we discuss these questions with Dr. Burcu Zeydan from the Mayo Clinic in this eMultipleSclerosis Review podcast. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 23 min
    MS and the COVID-19 Vaccine: What Do We Know and What Should We Do About It? 

    MS and the COVID-19 Vaccine: What Do We Know and What Should We Do About It? 

    COVID-19 vaccination. For many people with multiple sclerosis, it’s not a simple and straightforward process. The DMT they’re currently taking to control disease progression and moderate their symptoms — particularly if it’s a beta cell- depleting agent — may prevent the vaccine from working as it’s supposed to. What do clinicians need to know, and how should they explain it to their patients?  
    Dr. Joseph Sabatino from the University of California San Francisco presented the basics in his recent newsletter issue; now he brings that information into the clinic in this eMultipleSclerosis Review podcast. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 16 min
    Shared Decision Making in MS: The Why and The How

    Shared Decision Making in MS: The Why and The How

    Shared decision-making — what does it mean in multiple sclerosis? Can it really help providers more fully understand their patients’ concerns? Can it motivate patients to more readily and enthusiastically take ownership of their disease? And most important, how can it be developed in the clinic? 
    Join us in this eMultipleSclerosis Review podcast, as we talk about the why and how of shared decision-making in MS with PA Lisa Fox from the Department of Neurology at Johns Hopkins Hospital in Baltimore.  
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 21 min
    Clinical Approaches and DMT Choices

    Clinical Approaches and DMT Choices

    As the number of new MS therapies continues to grow, so does the uncertainty about which management approach — escalation or highly effective disease-modifying therapy — is best for each patient. What are the patient-specific factors that indicate the most appropriate DMT selection? What’s known about the potential longer-term risks associated with highly effective therapies? 
    That’s the focus of our discussion with Dr. Yujie Wang from the University of Washington and Johns Hopkins University, and Dr. Anne Damian-Yacoub from Johns Hopkins University in this eMultipleSclerosis Review podcast. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 23 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Lewis Howes
Aubrey Gordon & Michael Hobbes
Slumber Studios
Rob Dial and Kast Media